Kodiak Sciences (KOD)

• Market cap: $1.43B
• 1 day: 0.21%
• 5 days: -5.81%
• 1 month: 3.09%
• 3 months: -13.39%
• 6 months: 153.64%
• Year to date: -10.22%
• 1 year: 577.1%
• 5 years: -82.62%
• 10 years: 129.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Employees: 121